跳至主要内容
临床试验/ACTRN12613001379707
ACTRN12613001379707尚未招募未知

Prognostic Value of Assessing Hypoxia in Cervical and Lung Tumours Using 18FMISO PET During a Course of Radiation Therapy – Proof of Concept Study

Royal Brisbane and Women's Hospital Research Advisory Committee0 个研究点目标入组 10 人开始时间: 2013年12月16日最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Diagnosis

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Cervical Cancer:
  • FIGO 2008 stage IB1 & node positive, IB2, II, IIIB or IVA disease.
  • Histological diagnosis of squamous cell carcinoma, adenocarcinoma or adenosquamous cell carcinoma of the cervix
  • IASLC stage 2B to 3B.
  • Subject must have cytologically or histologically confirmed NSCLC
  • All participants:
  • Age >/= 18 years of age
  • ECOG performance status 0-2
  • Adequate bloods and renal function

排除标准

  • Any prior radiotherapy to the same area.
  • Previous chemotherapy for the cancer.
  • Evidence of distant metastases
  • Concurrent illness, including severe infection that may jeopardize the ability of the patient to undergo the procedures outlined in this protocol with reasonable safety
  • Serious medical or psychiatric conditions that might compromise management according to the protocol.
  • Inability to comply with all study requirements
  • Pregnancy, lactation, or inadequate contraception.

研究者

发起方
Royal Brisbane and Women's Hospital Research Advisory Committee

相似试验